NEW YORK (GenomeWeb News) – The University of Connecticut has inked a partnership with KeraFast to make stem cells developed at the university available globally.

KeraFast will market two stem cells lines created in 2009 from skin cells taken from patients with deletions of sections of chromosome 15 who develop Angelman Syndrome and Prader-Willi Syndrome. The stem cell lines were developed in the laboratories of UConn researchers Stormy Chamberlain and Marc Lalande.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.